Diagnostics; making a difference

Recent Blogs

The British In Vitro Diagnostics Association (BIVDA) is the national industry association for companies with major involvement and interest in the in vitro diagnostics (IVD) industry. BIVDA represents both manufacturers and distributors who are active in the UK. It is not just an association of UK diagnostic companies; all IVD companies, irrespective of their national origin, are eligible to become members of BIVDA.

As well as providing a range of support services for its members, BIVDA pursues a strategy of raising the awareness of the clinical and cost utility of diagnostics in the provision of effective healthcare in the UK. Our
Code of Conduct governing members business practice is an integral part of the association.

News

BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer
More
Cervical cancer screening samples to be tested for HPV first
More
BIVDA publishes report looking at the point of care testing environment in the UK
More
Government approves UK NSC's recommendation regarding the bowel cancer screening programme in England
More
BIVDA's response to the final recommendations of the Review on AMR
More
Discovery Awards launched to help teams progress ideas for the Longitude Prize
More
Supporting evidence published for the Accelerated Access Review
More
Final report of Carter Review published
More
Simon Stevens launches NHS Innovation ‘Test Beds’
More
BIVDA joins declaration by industry on combating antimicrobial resistance
More
BIVDA launches vision for increasing access to molecular diagnostics
More
Chris Wormald appointed as the new Permanent Secretary at the Department of Health
More
UK National Screening Committee publishes 11 recommendations
More
Two new NHS Genomic Medicine Centres join the 100,000 Genomes Project
More
BIVDA’s Response to the Spending Review and Autumn Statement
More
Public Health England publish second annual report on antibiotic resistance surveillance
More
All Party Parliamentary Group for Life Sciences supports funding calls ahead of the Comprehensive Spending Review 
More
Science and Technology Committee calls for increase in science funding
More
The Accelerated Access Review publishes its interim report
More

Precision Medicine Catapult announces initial six centres of excellence
More


 

 

See all BIVDA and sector news

The importance of IVDs in tackling the AMR challenge

click on picture for larger version

Map showing how CRP testing is reducing the use of antibiotics in Europe
Adapted from ‘Straight to the Point’ June 2015



Rapid diagnostics would reduce unnecessary prescription
‘Review on Antimicrobial Resistance.’


If not tackled, rising AMR could have a devastating impact 
‘Review on Antimicrobial Resistance.’

BIVDA dates


26 July - External Affairs WP
7 Sept - Digital Pathology WP
9 Sept - Regulatory Affairs WP
13 Sept - Diabetes WP
14 Sept - Procurement WP
6 Oct. - Precision Diagnostics WP
1-2 Nov - Regulatory Affairs Seminar  - Save the Date

Click here to find out more about our Events

Twitter Feed

Useful Links

For information on laboratory medicine and diagnostic tests

BIVDA is not responsible for the content of external internet/web sites

edma
IVD Australia
Lab Tests Online UK
Labs are Vital
Medical Lab Org
AF